EUVIMEDEUVIMED entdecken
Crossref

Concurrent Ferroptosis and Pyroptosis Induced by a Dual‐Organelle‐Targeted Type I/II AIE Photosensitizer for Bladder Cancer Immunotherapy

Yifan Cheng, Kun Zhou, Yuhang Chen, Yibo Mei, Zhongyu Wang, Wen-Jin Wang, Haowen Li, Yixuan Chen, Zonghang Liu, Jin Zeng, Yumei Luo, Dalin He und 2 weitere

Angewandte Chemie International Edition · 10.11.2025 · 64 (46)

DOI: 10.1002/anie.202509783 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 18.09.2025. Verfasst von Yifan Cheng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China. Hauptthemen laut MEDLINE: Ferroptosis, Pyroptosis, Photosensitizing Agents, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 87 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Science, Technology and Innovation Commission of Shenzhen Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The therapeutic efficacy and cell death modalities of photodynamic therapy (PDT) highly depend on reactive oxygen species (ROS) generation mediated by photosensitizers (PSs) and their subcellular localization. However, research exploring the potential mechanisms underlying ROS‐induced ferroptosis and pyroptosis remains scarce. In this study, we develop a type I/II aggregation‐induced emission photosensitizer (AIE PS), DFTBPPY (DY), that primarily accumulates in the endoplasmic reticulum (ER) and lipid droplets (LDs) to disrupt lipid homeostasis and induce concurrent cell death against bladder cancer. DY is selectively endocytosed by tumor cells and anchors in both ER and LDs. Upon laser irradiation, in situ DY can generate ROS to initiate oxidative stress and damage the functions of the ER and LDs. This disruption thereby initiates a lipid peroxidation‐cascading cell death pathway involving ferroptosis, pyroptosis, and immunogenic cell death (ICD), leading to potent antitumor effects. Our findings demonstrate that DY, as a dual‐organelle‐targeted PS, enhances therapeutic outcomes by orchestrating concurrent cell death mechanisms, which represents a promising alternative therapeutic strategy and highlights the potential of lipid imbalance in concurrent cell death for bladder cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisPyroptosisPhotosensitizing AgentsUrinary Bladder NeoplasmsImmunotherapyAntineoplastic AgentsHumansReactive Oxygen SpeciesPhotochemotherapyDrug Screening Assays, AntitumorCell Line, TumorMolecular Structure

Stichwörter der Autor:innen

AIE photosensitizerBladder cancerFerroptosis and pyroptosisImmunogenic cell deathLipid peroxidation

Substanzen

Photosensitizing AgentsReactive Oxygen SpeciesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
  • Guangdong Basic Research Center of Excellence for Aggregate Science, School of Science and Engineering, Shenzhen Institute of Aggregate Science and Technology, The Chinese University of Hong Kong, Shenzhen, Guangdong, 5…
  • Department of Cardiovascular Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
  • Clinical Translational Research Center of Aggregation-Induced Emission, The Second Affiliated Hospital, School of Science and Engineering, The Chinese University of Hong Kong, Shenzhen, Guangdong, 518172, China.

ORCID-Profile: Zheng Zhao

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Science, Technology and Innovation Commission of Shenzhen Municipality
  • Guangdong Basic and Applied Basic Research Foundation
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Cheng, Y., Zhou, K., Chen, Y., Mei, Y., Wang, Z., Wang, W. J., Li, H., Chen, Y., Liu, Z., Zeng, J., Luo, Y., He, D., Zhao, Z., & Tang, B. Z. (2025). Concurrent Ferroptosis and Pyroptosis Induced by a Dual‐Organelle‐Targeted Type I/II AIE Photosensitizer for Bladder Cancer Immunotherapy. Angewandte Chemie International Edition, 64(46). https://doi.org/10.1002/anie.202509783

Vancouver

Cheng Y, Zhou K, Chen Y, Mei Y, Wang Z, Wang WJ, et al. Concurrent Ferroptosis and Pyroptosis Induced by a Dual‐Organelle‐Targeted Type I/II AIE Photosensitizer for Bladder Cancer Immunotherapy. Angewandte Chemie International Edition. 2025;64(46). doi:10.1002/anie.202509783

BibTeX
@article{Cheng2025,
  author = {Cheng, Yifan and Zhou, Kun and Chen, Yuhang and Mei, Yibo and Wang, Zhongyu and Wang, Wen-Jin and Li, Haowen and Chen, Yixuan and Liu, Zonghang and Zeng, Jin and Luo, Yumei and He, Dalin and Zhao, Zheng and Tang, Ben Zhong},
  title = {Concurrent Ferroptosis and Pyroptosis Induced by a Dual‐Organelle‐Targeted Type I/II AIE Photosensitizer for Bladder Cancer Immunotherapy},
  journal = {Angewandte Chemie International Edition},
  year = {2025},
  volume = {64},
  number = {46},
  doi = {10.1002/anie.202509783}
}
Kostenlos starten →